Peppermint has raised $4.7 Million in New Funding

According to filings with the U.S. Securities and Exchange Commission, Peppermint has raised $4,700,000.00 in new Seed funding. The federal securities law requires the notice to be filed by companies that have sold securities without registration under the Securities Act of 1933 in an offering made under Rule 504 or 506 of Regulation D or Section 4(a)(5) of the Securities Act. A company must file this notice within 15 days after the first sale of securities in the offering. For this purpose, the date of first sale is the date on which the first investor is irrevocably contractually committed to invest. Each issuer of securities that sells its securities in reliance on an exemption provided in Regulation D or Section 4(a)(5) of the Securities Act of 1933 must file this notice containing the information requested with the U.S. Securities and Exchange Commission (SEC) and with the state(s) requiring it. If more than one issuer has sold its securities in the same transaction, all issuers should be identified in this filing with the SEC.

Investors in the company’s current round of funding include: Moxxie, Homebrew, Better Tomorrow Ventures, Layout Ventures, Digital Health Venture Partners, Night Capital, and angel investors Benjamin Mann and Evan Moore

About Peppermint
Peppermint is an AI-powered financial operations platform designed exclusively for clinical research. It combines intelligent automation with expert billers to capture, validate, invoice, collect, reconcile, and recover clinical-trial revenue within the CTMS, EDC, and accounting systems organizations already use. The platform reads contracts, tracks study activity, checks billable events against budgets and agreements, and provides a continuously updated view of each studys financial performance. Peppermint serves clinical research sites, site networks, hospital systems, academic medical centers, sponsors, and contract research organizations. It claims to reduce days sales outstanding threefold, improve time to invoice sixfold, reclaim 25% of staff time, and identify 15% in missing revenue. The company says it can connect to existing systems and deliver initial findings within a week, without requiring system replacement, data migration, or workflow disruption. Peppermint also highlights enterprise-grade security, HIPAA compliance, and SOC 2 certification in progress, and has raised $4.7 million to bring greater precision to clinical research finances. ?cite?web:0?.

To learn more, visit https://www.getpeppermint.ai/
Linkedin: https://www.linkedin.com/company/pepperminthealth/

Contact:
David Freeman, Co-Founder
https://www.linkedin.com/in/davidjacobfreeman/

SOURCE: http://www.intelligence360.io
Copyright (c) 2026 SI360 Inc. All rights reserved.